Benzinga

Benzinga

Benzinga

jueves, septiembre 03

Addus HomeCare Corp

ADUSNASDAQ
Trade with Public
Trade with Public
$118.17
3.623.16%
al cierre: Sep 2, 5:00 PM EST
$118.17
N/A
After hour: 4:00 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Addus HomeCare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Addus HomeCare (ADUS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

2S.Buy
9Buy
1Hold
1Sell
Consensus RatingOverweight# Analysts13Avg. Consensus PT$137Upside to Avg. PT+16.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 5, 2026RBC CapitalBen HendrixPT RaiseOutperform$130→$134
Jul 9, 2026BarclaysAndrew MokPT RaiseUnderweight$92→$96
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and raises the price target from $130 to $134.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $92 to $96.
Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

Citizens analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and maintains $142 price target.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on Addus HomeCare, Lowers Price Target to $142

Citizens analyst Constantine Davides maintains Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and lowers the price target from $150 to $142.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $102

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $112 to $102.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved